Daily price updates
What planify offer?
Join our channel partner program
Get info on Pharmeasy Board of Directors before buying, selling and investing - Read our Research report on Pharmeasy share & Information like - Pharmeasy Balance Sheet, Total Asset, Current Assets etc.
The current ratio of the company has been 1.63 in FY'21. This is because the current assets of the company have increased by 177% in FY'21 over FY'20 which is because of a large increase in the trade receivables as well as inventory of the company. On the other hand the current liabilities have increased by 665% in FY'21 over FY'20 which is mainly due to the increase in short term borrowing of the company.
Total Debt to Equity
The company's debt to equity ratio has been 0.24 in FY'21. Even though the company has taken a cash credit loan from a bank as well as taken unsecured loans in FY'21 increasing its total debt, the company's total equity has increased a lot due to a massive increase of INR 3,083 Cr in its reserves and surplus further increasing the other equity of the company. As a result the company has a low debt to equity ratio.
Shares outstanding numbers in None. Other numbers in ₹ Cr
* denotes current year's data